Medicure (OTCMKTS:MCUJF – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.05), Zacks reports. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.
Medicure Trading Up 7.6%
Shares of OTCMKTS MCUJF traded up $0.07 during mid-day trading on Friday, hitting $0.92. The company’s stock had a trading volume of 101 shares, compared to its average volume of 3,744. Medicure has a one year low of $0.67 and a one year high of $0.97. The company’s fifty day simple moving average is $0.76 and its 200-day simple moving average is $0.81. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.04 and a quick ratio of 0.73. The stock has a market cap of $9.55 million, a price-to-earnings ratio of -1.95 and a beta of 0.99.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Stories
- Five stocks we like better than Medicure
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
